Cochrane Abstracts
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"SARS‐CoV‐2‐neutralising Monoclonal Antibodies for Treatment of COVID‐19." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433921/all/Psychotherapy_for_depression_among_incurable_cancer_patients:_Cochrane_systematic_review. Accessed 07 June 2023.
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433921/all/Psychotherapy_for_depression_among_incurable_cancer_patients:_Cochrane_systematic_review. Accessed June 7, 2023.
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433921/all/Psychotherapy_for_depression_among_incurable_cancer_patients:_Cochrane_systematic_review
SARS‐CoV‐2‐neutralising Monoclonal Antibodies for Treatment of COVID‐19 [Internet]. In: Cochrane Abstracts. [cited 2023 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433921/all/Psychotherapy_for_depression_among_incurable_cancer_patients:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
ID - 433921
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433921/all/Psychotherapy_for_depression_among_incurable_cancer_patients:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
